Ovation Science Inc. (OVATF) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ovation Science Inc. (OVATF), Healthcare sektöründe faaliyet gösteriyor, son olarak $'dan işlem görüyor ve 0 piyasa değerine sahip. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 61/100 puan alıyor.
Son analiz: 16 Mar 2026Ovation Science Inc. (OVATF) Sağlık ve Boru Hattı Genel Bakışı
Ovation Science Inc. focuses on developing and marketing cannabis and hemp-based topical products using its patented Invisicare drug delivery technology. With operations in Canada, the United States, and Mexico, the company targets the health and wellness market through its Ovation and BASKiN brands, differentiating itself through innovative delivery systems.
Yatırım Tezi
Ovation Science Inc. presents a focused investment opportunity within the cannabis and hemp-based topical product market. The company's patented Invisicare technology provides a competitive edge in delivering cannabinoid-infused solutions. Key value drivers include expanding market penetration in Canada, the United States, and Mexico, along with the potential for new product development and licensing agreements. A gross margin of 81.5% indicates strong pricing power. However, the company's negative profit margin of -651.1% and limited market capitalization pose significant risks. Successful execution of its growth strategies and achieving profitability are critical for long-term value creation. Upcoming catalysts include potential regulatory changes in the cannabis industry and expansion into new geographic markets.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Patented Invisicare technology offers a unique drug delivery system for topical cannabis and hemp products.
- Gross margin of 81.5% demonstrates strong potential for profitability if sales volume increases.
- Operations in Canada, the United States, and Mexico provide access to key cannabis markets.
- Diverse product portfolio includes health and wellness, skincare, and sanitization products.
- Market Cap of $0.00B indicates the company is a microcap stock with high growth potential but also high risk.
Rakipler & Benzerleri
Güçlü Yönler
- Patented Invisicare drug delivery technology
- Established brands in key markets
- Diverse product portfolio
- Experienced management team
Zayıflıklar
- Negative profit margin
- Limited market capitalization
- Dependence on regulatory approvals
- Intense competition
Katalizörler
- Upcoming: Potential regulatory changes in the cannabis industry could expand market access.
- Ongoing: Expansion into new geographic markets will drive revenue growth.
- Ongoing: Strategic partnerships and licensing agreements can increase market reach.
- Upcoming: New product development and launches will enhance product portfolio.
- Ongoing: Increased brand awareness and marketing efforts will drive sales.
Riskler
- Potential: Changing regulatory landscape could negatively impact operations.
- Ongoing: Increased competition in the cannabis market could erode market share.
- Potential: Product liability risks associated with cannabis products.
- Potential: Economic downturn could reduce consumer spending on discretionary items.
- Ongoing: Dependence on regulatory approvals for new products and markets.
Büyüme Fırsatları
- Expansion into New Therapeutic Areas: Ovation Science can leverage its Invisicare technology to develop topical products targeting specific therapeutic areas such as pain management, dermatology, and wound healing. The global market for topical pain relief products is projected to reach $15.7 billion by 2027, presenting a significant opportunity for Ovation Science to expand its product offerings and capture market share. Timeline: 2-3 years.
- Geographic Expansion: The company can further expand its presence in existing markets and enter new geographic regions where cannabis and hemp products are legal. The European cannabis market is projected to reach €3.2 billion by 2025, offering a substantial growth opportunity for Ovation Science to establish a foothold in this emerging market. Timeline: Ongoing.
- Strategic Partnerships and Licensing Agreements: Ovation Science can pursue strategic partnerships with established pharmaceutical companies, retailers, and distributors to expand its market reach and access new customer segments. Licensing its Invisicare technology to other companies can also generate revenue and increase brand awareness. Timeline: Ongoing.
- New Product Development: The company can invest in research and development to create new and innovative cannabis and hemp-based products that address unmet needs in the market. This includes exploring new delivery methods, formulations, and ingredients to enhance product efficacy and appeal. Timeline: 1-2 years.
- Increased Brand Awareness and Marketing Efforts: Ovation Science can invest in marketing and advertising campaigns to increase brand awareness and drive sales of its products. This includes leveraging social media, influencer marketing, and public relations to reach target audiences and promote the benefits of its products. Timeline: Ongoing.
Fırsatlar
- Expansion into new therapeutic areas
- Geographic expansion into new markets
- Strategic partnerships and licensing agreements
- New product development
Tehditler
- Changing regulatory landscape
- Increased competition
- Product liability risks
- Economic downturn
Rekabet Avantajları
- Patented Invisicare drug delivery technology provides a competitive advantage.
- Established brands and distribution channels in key markets.
- Focus on innovation and product development.
- Expertise in cannabis and hemp product formulation and manufacturing.
OVATF Hakkında
Ovation Science Inc., established in 2017 and headquartered in Vancouver, Canada, specializes in the creation and distribution of cannabis and hemp-based products. The company's core technology, Invisicare, is a patented drug delivery system designed for topical and transdermal applications. This technology is central to the development of skincare and wellness products infused with hemp seed oil and cannabis. Ovation Science markets its products under several brands, including Ovation and BASKiN, which offer a range of topical solutions. Additionally, the company provides cannabidiol-infused health and wellness products under the Invibe MD brand, skincare solutions under the ARLO CBD name, and hand sanitizers under the DermSafe brand. Ovation Science operates in Canada, the United States, and Mexico, holding sublicenses for cannabis-based products and the Lighthouse brand for licensed dispensaries in the United States. The company aims to leverage its innovative technology and diverse product portfolio to capture a significant share of the growing cannabis and hemp market.
Ne Yaparlar
- Develops and commercializes topical cannabis and hemp products.
- Utilizes patented Invisicare drug delivery technology.
- Offers cannabidiol-infused health and wellness solutions.
- Provides skincare solutions under the ARLO CBD brand.
- Markets hand sanitizers under the DermSafe name.
- Holds sublicenses for cannabis-based products.
- Operates in Canada, the United States, and Mexico.
İş Modeli
- Develops and manufactures cannabis and hemp-based topical products.
- Markets and sells products through its own brands and distribution channels.
- Generates revenue through product sales and licensing agreements.
- Focuses on innovation and product development to maintain a competitive edge.
Sektör Bağlamı
Ovation Science Inc. operates within the rapidly expanding cannabis and hemp industry, which is experiencing significant growth due to increasing legalization and acceptance of cannabis-based products for medicinal and recreational use. The market is characterized by intense competition, with numerous companies vying for market share in various segments, including topicals, edibles, and beverages. Ovation Science's focus on topical applications and its patented Invisicare technology position it to capitalize on the growing demand for innovative and effective cannabis-infused products. The company faces competition from both established pharmaceutical companies and emerging cannabis startups.
Kilit Müşteriler
- Consumers seeking topical cannabis and hemp products for health and wellness.
- Patients seeking relief from pain, inflammation, and other conditions.
- Retailers and dispensaries that sell cannabis and hemp products.
- Companies that license Ovation Science's Invisicare technology.
Finansallar
Grafik & Bilgi
Ovation Science Inc. (OVATF) hisse senedi fiyatı: Price data unavailable
Son Haberler
OVATF için son haber bulunmamaktadır.
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
OVATF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
OVATF için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, OVATF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Yönetim: Terry H. Howlett
CEO
Terry H. Howlett serves as the CEO of Ovation Science Inc. His background includes extensive experience in the pharmaceutical and healthcare industries. Prior to joining Ovation Science, he held leadership positions at various companies, focusing on product development, marketing, and sales. His expertise spans across multiple therapeutic areas, including dermatology and pain management. Howlett's experience in bringing innovative products to market is expected to drive Ovation Science's growth strategy.
Sicil: Under Terry Howlett's leadership, Ovation Science has focused on expanding its product portfolio and market reach. Key milestones include the development and launch of new cannabis and hemp-based topical products, as well as the establishment of strategic partnerships to expand distribution channels. Howlett's strategic decisions have been instrumental in positioning Ovation Science as a leader in the cannabis topical market.
OVATF OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, indicating that Ovation Science Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, which can increase investment risk.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited financial disclosure increases investment risk.
- Low trading volume and wide bid-ask spreads can lead to price volatility.
- Fewer regulatory requirements compared to major exchanges.
- Potential for fraud or manipulation.
- Higher risk of delisting or going out of business.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Understand the risks associated with investing in OTC stocks.
- Patented Invisicare technology.
- Operations in Canada, the United States, and Mexico.
- Experienced management team.
- Presence of established brands.
OVATF Hakkında Sıkça Sorulan Sorular
OVATF için değerlendirilmesi gereken temel faktörler nelerdir?
Ovation Science Inc. (OVATF) şu anda yapay zeka skoru 61/100, orta puanı gösteriyor. Temel güçlü yan: Patented Invisicare drug delivery technology. İzlenmesi gereken birincil risk: Potential: Changing regulatory landscape could negatively impact operations.. Bu bir finansal tavsiye değildir.
OVATF MoonshotScore'u nedir?
OVATF şu anda MoonshotScore'da 61/100 (Derece B) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
OVATF verileri ne sıklıkla güncellenir?
OVATF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler OVATF hakkında ne diyor?
OVATF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
OVATF'a yatırım yapmanın riskleri nelerdir?
OVATF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Changing regulatory landscape could negatively impact operations.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
OVATF'ın P/E oranı nedir?
OVATF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için OVATF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
OVATF aşırı değerli mi, yoksa düşük değerli mi?
Ovation Science Inc. (OVATF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
OVATF'ın temettü verimi nedir?
Ovation Science Inc. (OVATF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Financial data is limited due to OTC status.
- AI analysis is pending.